Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
14.78
-0.82 (-5.26%)
Aug 14, 2025, 2:06 PM - Market open

Rapport Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
55.0756.8170.1731.16
Short-Term Investments
205.38248.4877.31-
Cash & Short-Term Investments
260.45305.28147.4831.16
Cash Growth
-22.52%107.00%373.31%-
Prepaid Expenses
9.690.31.50.11
Restricted Cash
0.110.110.09-
Other Current Assets
-4.121.81-
Total Current Assets
270.24309.8150.8731.27
Property, Plant & Equipment
14.224.9740.34
Long-Term Deferred Charges
0.3-0.3-
Other Long-Term Assets
0.730.160.25-
Total Assets
285.5314.93155.4231.6
Accounts Payable
3.181.952.51.45
Accrued Expenses
6.946.085.630.21
Current Portion of Leases
1.760.740.67-
Total Current Liabilities
11.888.778.81.66
Long-Term Debt
--4.210.44
Long-Term Leases
10.10.741.48-
Total Liabilities
21.989.5114.4812.1
Common Stock
0.040.0400.03
Additional Paid-In Capital
438.09429.6619.80.56
Retained Earnings
-174.54-123.75-45.44-10.65
Comprehensive Income & Other
-0.08-0.520-
Total Common Equity
263.51305.43-25.63-10.06
Shareholders' Equity
263.51305.43140.9419.51
Total Liabilities & Equity
285.5314.93155.4231.6
Total Debt
11.861.486.3510.44
Net Cash (Debt)
248.58303.8141.1320.72
Net Cash Growth
-25.64%115.26%581.01%-
Net Cash Per Share
7.0514.6593.7326.66
Filing Date Shares Outstanding
36.536.54.170.78
Total Common Shares Outstanding
36.536.584.170.78
Working Capital
258.36301.04142.0729.61
Book Value Per Share
7.228.35-6.15-12.95
Tangible Book Value
263.51305.43-25.63-10.06
Tangible Book Value Per Share
7.228.35-6.15-12.95
Machinery
4.353.781.760.3
Construction In Progress
-0.430.030.06
Leasehold Improvements
0.280.280.26-
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q